Valuation: Abbott Laboratories

Market Cap 19TCr 16TCr 15TCr 14TCr 26TCr 17,63200Cr 26TCr 1,76900Cr 69TCr 8,81400Cr 70TCr 68TCr 29,20400Cr P/E 2026 *
30.7x
P/E 2027 * 23.7x
Enterprise Value 21TCr 18TCr 17TCr 16TCr 29TCr 19,93000Cr 30TCr 2,00000Cr 78TCr 9,96300Cr 79TCr 77TCr 33,01200Cr EV / Sales 2026 *
4.17x
EV / Sales 2027 * 3.78x
Free-Float
86.16%
Yield 2026 *
2.41%
Yield 2027 * 2.56%
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 19TCr
-0.81%-1.14%-4.18%+2.20% 11TCr
+2.21%-4.32%+4.13%+64.98% 6TCr
+2.63%+4.85%+48.14%+59.49% 5.39TCr
-0.45%+2.13%-5.04%-37.27% 4.69TCr
+3.13%+3.95% - - 3.42TCr
-1.48%+16.19%+14.05%-27.73% 3.29TCr
+4.59%+3.59%+46.44%-6.92% 2.45TCr
+2.15%+0.74%+1.58%+2.67% 2.27TCr
+0.50%+3.29%-9.38%+5.02% 2.17TCr
Average +0.50%+5.19%+11.97%+7.81% 4.53TCr
Weighted average by Cap. +0.22%+4.29%+9.57%+12.55%

Financials

2026 *2027 *
Net sales 5.03TCr 4.37TCr 4.07TCr 3.74TCr 7.08TCr 4,78500Cr 7.15TCr 48TCr 19TCr 2,39200Cr 19TCr 18TCr 7,92600Cr 5.46TCr 4.75TCr 4.42TCr 4.06TCr 7.69TCr 5,19800Cr 7.77TCr 52TCr 20TCr 2,59900Cr 21TCr 20TCr 8,61000Cr
Net income 625.49Cr 543.11Cr 506.38Cr 465.19Cr 879.78Cr 59TCr 889.44Cr 5.97TCr 2.33TCr 30TCr 2.35TCr 2.3TCr 99TCr 792.32Cr 687.97Cr 641.45Cr 589.27Cr 1.11TCr 75TCr 1.13TCr 7.56TCr 2.96TCr 38TCr 2.98TCr 2.91TCr 1,24800Cr
Net Debt 2.42TCr 2.1TCr 1.96TCr 1.8TCr 3.4TCr 2,29900Cr 3.44TCr 23TCr 9.02TCr 1,14900Cr 9.07TCr 8.88TCr 3,80700Cr 2.14TCr 1.86TCr 1.73TCr 1.59TCr 3.01TCr 2,03700Cr 3.05TCr 20TCr 7.99TCr 1,01800Cr 8.04TCr 7.87TCr 3,37400Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BBB